Comparison of SARS-CoV-2 molecular detection in nasopharyngeal swab, saliva, and gargle samples

G Genelhoud, D Adamoski, RN Spalanzani… - … and infectious disease, 2022 - Elsevier
The nasopharyngeal swab is a gold standard for detecting SARS-CoV-2. However, the
inconvenience of this method compelled us to compare its efficiency with saliva and gargle …

[HTML][HTML] SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus

MI Andersson, CV Arancibia-Carcamo… - Wellcome open …, 2020 - ncbi.nlm.nih.gov
Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses
PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been …

Low rate of RNAemia in blood donations collected during the first wave of COVID‐19 in France

S Le Cam, P Gallian, C Ricard, C Narboux… - …, 2022 - Wiley Online Library
Background To investigate the transmission of SARS‐CoV‐2 via blood, we conducted
retrospective molecular screening in blood donated during the first pandemic peak in the …

Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department

RHT Nijhuis, A Russcher, GJ de Jong, E Jong… - Journal of Clinical …, 2020 - Elsevier
Correct and reliable identification of SARS-CoV-2 in COVID-19 suspected patients is
essential for diagnosis. Respiratory samples should always be tested with real-time PCR for …

Prevalence and Clinical Characteristics of Coronavirus Disease 2019 Seen at a Testing Centre in Lagos Nigeria.

AO Salako, OS Amoo, OO Odubela… - West African Journal …, 2021 - europepmc.org
Background The SARS-CoV-2 infection continues to ravage the global community since it
was declared a pandemic. The socio-demographic and clinical characteristics defining the …

A fast and accessible method for the isolation of RNA, DNA, and protein to facilitate the detection of SARS-CoV-2

JC Ponce-Rojas, MS Costello, DA Proctor… - Journal of clinical …, 2021 - Am Soc Microbiol
Management of the coronavirus disease 2019 (COVID-19) pandemic requires widespread
testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A main limitation …

[HTML][HTML] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy

L Mascaretti, V De Angelis, P Berti - Blood Transfusion, 2020 - ncbi.nlm.nih.gov
Just over three months after the diagnosis of the first cases in the city of Wuhan, in the Hubei
province of China, the SARS-CoV-2 pandemic has become one of the most serious global …

Retrospective quantitative detection of SARS-CoV-2 by digital PCR showing high accuracy for low viral load specimens

R Lu, J Wang, M Li, J He, Y Wang, J Dong… - The Journal of Infection in …, 2022 - jidc.org
Introduction: Accurate detection of severe acute respiratory syndrome coronavirus 2 is
critical for diagnosis and disease status evaluation of Coronavirus disease 2019. We …

[HTML][HTML] Transfusion requirements in patients with COVID‐19

AP Worrall, C Kelly, A O'Neill, N Reidy… - European journal of …, 2021 - ncbi.nlm.nih.gov
Since the emergence of COVID-19 in late 2019, our knowledge of the clinical implications of
infection with SARS-CoV-2 has steadily grown. The clinical spectrum of COVID-19 is broad …

SARS-CoV-2 seroprevalence among whole blood donors during first wave of covid-19 pandemic in India

SR Chunchu, U Ravula, VK Gente, S Bacchu… - Indian Journal of …, 2022 - Springer
The current study aimed to estimate the seroprevalence of SARS-CoV-2 IgG (S-protein)
antibodies along with neutralizing assay (RBD-domain) among the whole blood donors …